Provectus Pharmaceuticals' Grant

Provectus Pharmaceuticals raised a round of funding on November 04, 2010. Investors include Qualifying Therapeutic Discovery Project.

Provectus Pharmaceuticals (OTCQB: PVCT) is a clinical-stage biopharmaceutical company developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. Provectus' investigat…

Articles about Provectus Pharmaceuticals' Grant: